Teladoc (TDOC) Tops Q4 EPS by 5c, guidance misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil falls almost 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Teladoc (TDOC) beats FQ4 earnings expectations but guidance falls short; shares slide
February 20, 2024 4:21 PM ESTShares of Teladoc Health (NYSE: TDOC) fell over 11% following the closing bell on Tuesday after the companys FQ4 revenue and FQ1 2024 guidance fell short of expectations.
The healthcare firm reported a loss per share of $0.17 for the quarter, compared to a loss per share of $0.22 expected by analysts. However, revenue came in at $660.53 million, missing the consensus estimate... More
